A new study involving the Medical University of Vienna shows how the multi-resistant fungus Candida auris utilizes carbon dioxide (CO₂) to survive on the skin and become resistant to antifungal therapies. The research team identified several new targets that could be used in the future to curb the spread and infections caused by Candida auris. Due to its rapid development of resistance to almost all available antifungal drugs, the World Health Organization (WHO) classifies the pathogen as a priority fungal pathogen.